Anzeige
Mehr »
Login
Freitag, 03.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Schnelle Produktionsaufnahme: Multi-Tenbagger-Potenzial direkt in Spanien?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
14 Leser
Artikel bewerten:
(0)

MedQuist Names Dominick J. Golio as Chief Financial Officer

MOUNT LAUREL, N.J., April 15 /PRNewswire-FirstCall/ -- MedQuist Inc. today announced it has named Dominick J. Golio as its new Chief Financial Officer. He joined MedQuist on April 13, 2009.

In his role as MedQuist's new CFO, Golio is responsible for directing all financial operations and controls, in addition to financial planning, treasury, financial analysis, investor relations, tax, and financial reporting. "Dominick's broad experience as a Chief Financial Officer will contribute significantly to the overall strategy of the company," said Peter Masanotti, President and CEO. "He has a successful track record in developing high performance teams and brings an exemplary combination of business judgment, professional skills and integrity to MedQuist."

Golio, 63, was most recently the North America Chief Financial Officer for D & M Holdings NA, a Bain Capital Holdings Portfolio Company. Prior to joining D & M Holdings, Golio was Senior Vice President/CFO at Belco Oil & Gas Corporation, an energy company previously listed on the New York Stock Exchange. He also held CFO positions at Millmaster Onyx Group, AEG Corporation NA, and Case Pomeroy & Company.

Golio holds a B.A. and Master's degree in Business Administration from Pace University and is a Certified Public Accountant.

MedQuist is a leading provider of medical transcription services, and a leader in technology-enabled clinical documentation workflow. MedQuist's enterprise solutions -- including mobile voice capture devices, speech recognition, Web-based workflow platforms, and a global network of medical editors -- help healthcare facilities improve patient care, increase physician satisfaction, and lower operational costs. For more information, please visit http://www.medquist.com/.

"Safe Harbor" Statement under the U.S. Private Securities Litigation Reform Act of 1995: Statements in this press release regarding MedQuist's business that are not historical facts are "forward-looking statements" that involve risks and uncertainties. Actual outcomes and results may differ materially from what is expressed or forecasted in forward-looking statements. As a result, forward-looking statements speak only as of the date they were made, and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

MedQuist Inc.

CONTACT: Robin Petty, Marketing Communications, of MedQuist Inc.,
+1-856-206-4715, rpetty@medquist.com

Web Site: http://www.medquist.com/

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2009 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.